ALPS Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.62M | Buy |
5,217
+4,198
| +412% | +$2.02M | 0.01% | 444 |
|
|
2026
Q1 | $501K | Sell |
1,019
-300
| -23% | -$163K | ﹤0.01% | 820 |
|
|
2025
Q4 | $764K | Buy |
1,319
+104
| +9% | +$58.8K | ﹤0.01% | 638 |
|
|
2025
Q3 | $589K | Sell |
1,215
-1,852
| -60% | -$862K | ﹤0.01% | 637 |
|
|
2025
Q2 | $1.24M | Sell |
3,067
-429
| -12% | -$179K | 0.01% | 457 |
|
|
2025
Q1 | $1.74M | Buy |
3,496
+568
| +19% | +$308K | 0.01% | 369 |
|
|
2024
Q4 | $1.52M | Sell |
2,928
-29
| -1% | -$15.9K | 0.01% | 388 |
|
|
2024
Q3 | $1.83M | Buy |
2,957
+1,744
| +144% | +$1.03M | 0.01% | 373 |
|
|
2024
Q2 | $671K | Sell |
1,213
-123
| -9% | -$70.5K | ﹤0.01% | 536 |
|
|
2024
Q1 | $776K | Buy |
1,336
+58
| +5% | +$32.5K | 0.01% | 540 |
|
|
2023
Q4 | $678K | Buy |
1,278
+70
| +6% | +$33.9K | 0.01% | 562 |
|
|
2023
Q3 | $611K | Sell |
1,208
-1,322
| -52% | -$704K | 0.01% | 569 |
|
|
2023
Q2 | $1.32M | Sell |
2,530
-2,620
| -51% | -$1.41M | 0.01% | 404 |
|
|
2023
Q1 | $2.97M | Sell |
5,150
-595
| -10% | -$335K | 0.03% | 235 |
|
|
2022
Q4 | $3.16M | Sell |
5,745
-477
| -8% | -$253K | 0.03% | 226 |
|
|
2022
Q3 | $3.16M | Sell |
6,222
-2,709
| -30% | -$1.52M | 0.03% | 215 |
|
|
2022
Q2 | $4.85M | Buy |
8,931
+1,860
| +26% | +$1.02M | 0.05% | 179 |
|
|
2022
Q1 | $4.18M | Sell |
7,071
-124
| -2% | -$71.2K | 0.05% | 138 |
|
|
2021
Q4 | $4.8M | Buy |
7,195
+99
| +1% | +$61.8K | 0.05% | 152 |
|
|
2021
Q3 | $4.05M | Sell |
7,096
-263
| -4% | -$144K | 0.04% | 186 |
|
|
2021
Q2 | $3.71M | Buy |
7,359
+970
| +15% | +$458K | 0.03% | 195 |
|
|
2021
Q1 | $2.92M | Buy |
6,389
+1,261
| +25% | +$602K | 0.03% | 220 |
|
|
2020
Q4 | $2.39M | Sell |
5,128
-197
| -4% | -$92.4K | 0.03% | 250 |
|
|
2020
Q3 | $2.35M | Buy |
5,325
+4,646
| +684% | +$1.92M | 0.03% | 213 |
|
|
2020
Q2 | $246K | Sell |
679
-78
| -10% | -$26.1K | ﹤0.01% | 659 |
|
|
2020
Q1 | $215K | Sell |
757
-5,611
| -88% | -$1.77M | ﹤0.01% | 728 |
|
|
2019
Q4 | $2.07M | Sell |
6,368
-255
| -4% | -$77.3K | 0.02% | 224 |
|
|
2019
Q3 | $1.93M | Buy |
6,623
+972
| +17% | +$278K | 0.02% | 213 |
|
|
2019
Q2 | $1.66M | Sell |
5,651
-1,147
| -17% | -$316K | 0.01% | 252 |
|
|
2019
Q1 | $1.86M | Sell |
6,798
-6,577
| -49% | -$1.64M | 0.01% | 231 |
|
|
2018
Q4 | $2.99M | Buy |
13,375
+1,831
| +16% | +$430K | 0.02% | 191 |
|
|
2018
Q3 | $2.82M | Buy |
+11,544
| New | +$2.66M | 0.02% | 211 |
|
Other funds holding TMO
ALPS Advisors's TMO Position: Q2 2026 in Review
ALPS Advisors increased its Thermo Fisher Scientific (TMO) stake by 412% in Q2 2026, buying an estimated $2.02M and bringing the position to 5,217 shares worth $2.62M. The position accounts for 0.01% of the portfolio, ranked #444.
ALPS Advisors first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $4.85M in Q2 2022. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- ALPS Advisors held 5,217 shares of Thermo Fisher Scientific worth $2.62M as of Q2 2026.
- ALPS Advisors bought 4,198 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.02M.
- Thermo Fisher Scientific made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #444 holding.
- ALPS Advisors first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- ALPS Advisors's Thermo Fisher Scientific position peaked at $4.85M in Q2 2022.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.